My Account
Video12 Dec 2023

How is AI Revolutionizing Drug Discovery?

Adam Spielman, Head of Health, Citi Global Insights and Andrew Hopkins, Founder and CEO, Exscientia discuss how AI impacts biopharma, including the extent to which AI is a threat to traditional biopharma companies, and how they should respond.


Sign up to receive our newsletter providing a roundup of recent content and updates on new reports.